In mouse and human organoids, treatment with SCFA led to an increase in the number of L-cells and glucose-induced GLP-1 secretion
Additionally, patients may prefer the weekly injection of semaglutide over the daily injections of liraglutide, as indicated by the lower discontinuation rates for weekly vs daily injections of GLP-1 receptor agonists observed in some studies [36,37,38,39]
Not surprisingly, among the predictive biomarkers and assays under development, a majority focusses on measuring AR activity and consist of transcriptomics signatures or genomics tools to measure ARs transcriptional output (e.g., ADT-RS score [41]) or ARs structural integrity (e.g., AR-ctDETECT [42])
Many researchers use both as part of their hair growth stack
Our goal is to reduce suffering and transform the health system in America one professional at a time